Literature DB >> 23818022

Uterine massage for preventing postpartum haemorrhage.

G Justus Hofmeyr1, Hany Abdel-Aleem, Mahmoud A Abdel-Aleem.   

Abstract

BACKGROUND: Postpartum haemorrhage (PPH) (bleeding from the genital tract after childbirth) is a major cause of maternal mortality and disability, particularly in under-resourced areas. In these settings, uterotonics are often not accessible. There is a need for simple, inexpensive techniques which can be applied in low-resourced settings to prevent and treat PPH. Uterine massage is recommended as part of the routine active management of the third stage of labour. However, it is not known whether it is effective. If shown to be effective, uterine massage would represent a simple intervention with the potential to have a major effect on PPH and maternal mortality in under-resourced settings.
OBJECTIVES: To determine the effectiveness of uterine massage after birth and before or after delivery of the placenta, or both, to reduce postpartum blood loss and associated morbidity and mortality. SEARCH
METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 April 2013). SELECTION CRITERIA: All published, unpublished and ongoing randomised controlled trials comparing uterine massage alone or in addition to uterotonics before or after delivery of the placenta, or both, with non-massage. DATA COLLECTION AND ANALYSIS: Two researchers independently considered trials for eligibility, assessed risk of bias and extracted the data using the agreed form. Data were checked for accuracy. The effect of uterine massage commenced before or after placental delivery were first assessed separately, and then the combined for an overall result. MAIN
RESULTS: This review included two randomised controlled trials. The first trial included 200 women who were randomised to receive uterine massage or no massage following delivery of the placenta, after active management of the third stage of labour including use of oxytocin. The numbers of women with blood loss more than 500 mL was small, with no statistically significant difference (risk ratio (RR) 0.52, 95% confidence interval (CI) 0.16 to 1.67). There were no cases of retained placenta in either group. The mean blood loss was significantly less in the uterine massage group at 30 minutes (mean difference (MD) -41.60 mL, 95% CI -75.16 to -8.04) and 60 minutes after trial entry (MD -77.40 mL, 95% CI -118.71 to -36.09). The need for additional uterotonics was significantly reduced in the uterine massage group (RR 0.20, 95% CI 0.08 to 0.50).For use of uterine massage before and after delivery of the placenta, one trial recruited 1964 women in Egypt and South Africa. Women were assigned to receive oxytocin, uterine massage or both after delivery of the baby but before delivery of the placenta. There was no added benefit for uterine massage plus oxytocin over oxytocin alone as regards blood loss greater than or equal to 500 mL (average RR 1.56, 95% CI 0.44, 5.49; random-effects) or need for additional use of uterotonics (RR 1.02, 95% CI 0.56 to 1.85).The two trials were combined to examine the effect of uterine massage commenced either before or after delivery of the placenta. There was substantial heterogeneity with respect to the blood loss 500 mL or more after trial entry. The average effect using a random-effects model found no statistically significant differences between groups (average RR 1.14, 95% CI 0.39 to 3.32; random-effects). AUTHORS'
CONCLUSIONS: The results of this review are inconclusive, and should not be interpreted as a reason to change current practice. Due to the limitations of the included trials, more trials with sufficient numbers of women are needed in order to estimate the effects of sustained uterine massage. All the women compared in this review received oxytocin as part of the active management of labour. Recent research suggests that once an oxytocic has been given, there is limited scope for further reduction in postpartum blood loss. Trials of uterine massage in settings where uterotonics are not available, and which measure women's experience of the procedure, are needed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23818022      PMCID: PMC8924870          DOI: 10.1002/14651858.CD006431.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  9 in total

1.  Joint statement: management of the third stage of labour to prevent post-partum haemorrhage.

Authors: 
Journal:  J Midwifery Womens Health       Date:  2004 Jan-Feb       Impact factor: 2.388

2.  Uterine massage to reduce postpartum hemorrhage after vaginal delivery.

Authors:  Hany Abdel-Aleem; Mandisa Singata; Mahmoud Abdel-Aleem; Nolundi Mshweshwe; Xoliswa Williams; G Justus Hofmeyr
Journal:  Int J Gynaecol Obstet       Date:  2010-10       Impact factor: 3.561

3.  Reducing postpartum hemorrhage in Africa.

Authors:  J V Lazarus; A Lalonde
Journal:  Int J Gynaecol Obstet       Date:  2005-01       Impact factor: 3.561

4.  A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints.

Authors:  Roger M Harbord; Matthias Egger; Jonathan A C Sterne
Journal:  Stat Med       Date:  2006-10-30       Impact factor: 2.373

5.  Uterine massage and postpartum blood loss.

Authors:  H Abdel-Aleem; G J Hofmeyr; M Shokry; E El-Sonoosy
Journal:  Int J Gynaecol Obstet       Date:  2006-05-06       Impact factor: 3.561

Review 6.  Uterine massage for preventing postpartum haemorrhage.

Authors:  G Justus Hofmeyr; Hany Abdel-Aleem; Mahmoud A Abdel-Aleem
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

7.  Bias in meta-analysis detected by a simple, graphical test.

Authors:  M Egger; G Davey Smith; M Schneider; C Minder
Journal:  BMJ       Date:  1997-09-13

8.  A community based investigation of causes of maternal mortality in rural and urban Zimbabwe. Maternal Mortality Study Group.

Authors:  S Fawcus; M T Mbizvo; G Lindmark; L Nystrom
Journal:  Cent Afr J Med       Date:  1995-04

9.  Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial.

Authors:  Mariana Widmer; Jennifer Blum; G Justus Hofmeyr; Guillermo Carroli; Hany Abdel-Aleem; Pisake Lumbiganon; Thi Nhu Ngoc Nguyen; Daniel Wojdyla; Jadsada Thinkhamrop; Mandisa Singata; Luciano E Mignini; Mahmoud Ahmad Abdel-Aleem; Son Thach Tran; Beverly Winikoff
Journal:  Lancet       Date:  2010-05-22       Impact factor: 79.321

  9 in total
  15 in total

1.  FIGO recommendations on the management of postpartum hemorrhage 2022.

Authors:  Maria Fernanda Escobar; Anwar H Nassar; Gerhard Theron; Eythan R Barnea; Wanda Nicholson; Diana Ramasauskaite; Isabel Lloyd; Edwin Chandraharan; Suellen Miller; Thomas Burke; Gabriel Ossanan; Javier Andres Carvajal; Isabella Ramos; Maria Antonia Hincapie; Sara Loaiza; Daniela Nasner
Journal:  Int J Gynaecol Obstet       Date:  2022-03       Impact factor: 4.447

Review 2.  Prevention of postpartum hemorrhage in low-resource settings: current perspectives.

Authors:  Ndola Prata; Suzanne Bell; Karen Weidert
Journal:  Int J Womens Health       Date:  2013-11-13

3.  Uterotonic use immediately following birth: using a novel methodology to estimate population coverage in four countries.

Authors:  Jim Ricca; Vikas Dwivedi; John Varallo; Gajendra Singh; Suranjeen Prasad Pallipamula; Nazir Amade; Maria de Luz Vaz; Dustan Bishanga; Marya Plotkin; Bushra Al-Makaleh; Stephanie Suhowatsky; Jeffrey Michael Smith
Journal:  BMC Health Serv Res       Date:  2015-01-22       Impact factor: 2.655

4.  Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial.

Authors:  Loïc Sentilhes; Valérie Daniel; Astrid Darsonval; Philippe Deruelle; Delphine Vardon; Franck Perrotin; Camille Le Ray; Marie-Victoire Senat; Norbert Winer; Françoise Maillard; Catherine Deneux-Tharaux
Journal:  BMC Pregnancy Childbirth       Date:  2015-06-14       Impact factor: 3.007

5.  The Routine Use of Prophylactic Oxytocin in the Third Stage of Labor to Reduce Maternal Blood Loss.

Authors:  Akiko Kuzume; So Sugimi; Sachie Suga; Hiroshi Yamashita; Ichiro Yasuhi
Journal:  J Pregnancy       Date:  2017-09-11

Review 6.  Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.

Authors:  Tomas Pantoja; Edgardo Abalos; Evelina Chapman; Claudio Vera; Valentina P Serrano
Journal:  Cochrane Database Syst Rev       Date:  2016-04-14

Review 7.  Essential childbirth and postnatal interventions for improved maternal and neonatal health.

Authors:  Rehana A Salam; Tarab Mansoor; Dania Mallick; Zohra S Lassi; Jai K Das; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-08-21       Impact factor: 3.223

8.  Essential interventions: implementation strategies and proposed packages of care.

Authors:  Zohra S Lassi; Rohail Kumar; Tarab Mansoor; Rehana A Salam; Jai K Das; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-08-21       Impact factor: 3.223

9.  Variations in Postpartum Hemorrhage Management among Midwives: A National Vignette-Based Study.

Authors:  A Rousseau; P Rozenberg; E Perrodeau; C Deneux-Tharaux; P Ravaud
Journal:  PLoS One       Date:  2016-04-04       Impact factor: 3.240

10.  Cost effectiveness analysis of carbetocin during cesarean section in a high volume maternity unit.

Authors:  Hian Yan Voon; Asrul A Shafie; Mohamad A Bujang; Haris N Suharjono
Journal:  J Obstet Gynaecol Res       Date:  2017-10-13       Impact factor: 1.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.